VICO — Vicore Pharma Holding AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Vicore Pharma Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	265	319	371	262	483
Net Total Accounts Receivable
Net Total Receivables	1.43	5.35	1.42	2.18	3.24
Prepaid Expenses
Total Current Assets	267	328	378	270	496
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.332	0.252	0.401	0.117	0.025
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	341	407	451	338	498
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17	48.1	65.7	46.4	41
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19.5	52	67.9	48.9	42.4
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	322	355	383	289	455
Total Liabilities & Shareholders' Equity	341	407	451	338	498
Total Common Shares Outstanding